154 related articles for article (PubMed ID: 36960537)
21. Simple generation of albino C57BL/6J mice with G291T mutation in the tyrosinase gene by the CRISPR/Cas9 system.
Mizuno S; Dinh TT; Kato K; Mizuno-Iijima S; Tanimoto Y; Daitoku Y; Hoshino Y; Ikawa M; Takahashi S; Sugiyama F; Yagami K
Mamm Genome; 2014 Aug; 25(7-8):327-34. PubMed ID: 24879364
[TBL] [Abstract][Full Text] [Related]
22. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-Associated Endonuclease Cas9-Mediated Homology-Independent Integration for Generating Quality Control Materials for Clinical Molecular Genetic Testing.
Lin G; Zhang K; Peng R; Han Y; Xie J; Li J
J Mol Diagn; 2018 May; 20(3):373-380. PubMed ID: 29680088
[TBL] [Abstract][Full Text] [Related]
23. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.
Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T
Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618
[TBL] [Abstract][Full Text] [Related]
24. Microinjection-based generation of mutant mice with a double mutation and a 0.5 Mb deletion in their genome by the CRISPR/Cas9 system.
Hara S; Kato T; Goto Y; Kubota S; Tamano M; Terao M; Takada S
J Reprod Dev; 2016 Oct; 62(5):531-536. PubMed ID: 27396308
[TBL] [Abstract][Full Text] [Related]
25. Organoids for the Study of Liver Cancer.
Wang H; Calvisi DF; Chen X
Semin Liver Dis; 2021 Jan; 41(1):19-27. PubMed ID: 33764482
[TBL] [Abstract][Full Text] [Related]
26. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
[TBL] [Abstract][Full Text] [Related]
27. Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression.
Koo T; Yoon AR; Cho HY; Bae S; Yun CO; Kim JS
Nucleic Acids Res; 2017 Jul; 45(13):7897-7908. PubMed ID: 28575452
[TBL] [Abstract][Full Text] [Related]
28. Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis.
Nanki K; Toshimitsu K; Takano A; Fujii M; Shimokawa M; Ohta Y; Matano M; Seino T; Nishikori S; Ishikawa K; Kawasaki K; Togasaki K; Takahashi S; Sukawa Y; Ishida H; Sugimoto S; Kawakubo H; Kim J; Kitagawa Y; Sekine S; Koo BK; Kanai T; Sato T
Cell; 2018 Aug; 174(4):856-869.e17. PubMed ID: 30096312
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.
Ryu N; Kim MA; Choi DG; Kim YR; Sonn JK; Lee KY; Kim UK
Gene; 2019 Jun; 703():83-90. PubMed ID: 30898719
[TBL] [Abstract][Full Text] [Related]
30. Murine trophoblast organoids as a model for trophoblast development and CRISPR-Cas9 screening.
Mao Q; Ye Q; Xu Y; Jiang J; Fan Y; Zhuang L; Liu G; Wang T; Zhang Z; Feng T; Kong S; Lu J; Zhang H; Wang H; Lin CP
Dev Cell; 2023 Dec; 58(24):2992-3008.e7. PubMed ID: 38056451
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses.
Wang D; Mou H; Li S; Li Y; Hough S; Tran K; Li J; Yin H; Anderson DG; Sontheimer EJ; Weng Z; Gao G; Xue W
Hum Gene Ther; 2015 Jul; 26(7):432-42. PubMed ID: 26086867
[TBL] [Abstract][Full Text] [Related]
32. Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes.
Mashiko D; Young SA; Muto M; Kato H; Nozawa K; Ogawa M; Noda T; Kim YJ; Satouh Y; Fujihara Y; Ikawa M
Dev Growth Differ; 2014 Jan; 56(1):122-9. PubMed ID: 24372541
[TBL] [Abstract][Full Text] [Related]
33. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
[TBL] [Abstract][Full Text] [Related]
34. Optimisation of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 : single-guide RNA (sgRNA) delivery system in a goat model.
Huang Y; Ding Y; Liu Y; Zhou S; Ding Q; Yan H; Ma B; Zhao X; Wang X; Chen Y
Reprod Fertil Dev; 2019 Aug; 31(9):1533-1537. PubMed ID: 31079595
[TBL] [Abstract][Full Text] [Related]
35. Essential function of NHE8 in mouse retina demonstrated by AAV-mediated CRISPR/Cas9 knockdown.
Xia CH; Ferguson I; Li M; Kim A; Onishi A; Li L; Su B; Gong X
Exp Eye Res; 2018 Nov; 176():29-39. PubMed ID: 29958869
[TBL] [Abstract][Full Text] [Related]
36. Embryonic Stem Cells Derived Kidney Organoids as Faithful Models to Target Programmed Nephrogenesis.
Tan Z; Shan J; Rak-Raszewska A; Vainio SJ
Sci Rep; 2018 Nov; 8(1):16618. PubMed ID: 30413738
[TBL] [Abstract][Full Text] [Related]
37. Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research.
Eun K; Park MG; Jeong YW; Jeong YI; Hyun SH; Hwang WS; Kim SH; Kim H
BMC Biotechnol; 2019 Jan; 19(1):1. PubMed ID: 30606176
[TBL] [Abstract][Full Text] [Related]
38. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line.
Chu VT; Graf R; Wirtz T; Weber T; Favret J; Li X; Petsch K; Tran NT; Sieweke MH; Berek C; Kühn R; Rajewsky K
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12514-12519. PubMed ID: 27729526
[TBL] [Abstract][Full Text] [Related]
39. Rapid generation and selection of Cas9-engineering TRP53 R172P mice that do not have off-target effects.
Zheng G; Zhu Q; Dong J; Lin X; Zhu C
BMC Biotechnol; 2019 Nov; 19(1):74. PubMed ID: 31703569
[TBL] [Abstract][Full Text] [Related]
40. Modeling of Autism Using Organoid Technology.
Choi H; Song J; Park G; Kim J
Mol Neurobiol; 2017 Dec; 54(10):7789-7795. PubMed ID: 27844287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
